Rationale for use mefloquine for COVID-19 treatment

Abstract

Currently, the use of mefloquine in patients with COVID-19 does not have sufficient scientific justification and, given the unfavorable efficacy and safety profile, cannot be considered for routine use in clinical practice.

Keywords

• коронавирус
• мефлохин
• covid-19